$LAZ

After two August sales, Lazard (NYSE: LAZ) ex-director plans another stock sale

Lazard (LAZ) ex-director Andrew Alper plans to sell up to 10,000 shares via Goldman Sachs, following prior sales. Shares were acquired as restricted stock awards on 07/28/2026. The sale is under Rule 144.

Original reporting
Published Sep 1, 2026, 9:12 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 2, 2026, 5:04 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$LAZ
Neutral
medium confidence
Mentioned
$LAZ
Relevance
4/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$LAZNeutralLow
01

Why it matters

The disclosure adds a new data point for traders monitoring insider activity, but the scale is small.

02

Market read

New insider sale filing; modest potential price impact.

03

What to watch

If the shares are sold at a discount, it may signal internal concerns not reflected in public filings.

Relevance 4/10Novelty 4/10Timing: today

Background

Form 144 filing by a former Lazard director indicating an upcoming insider sale.

Company-level read

Ticker impact

$LAZNeutralMedium confidence
Context

Former board member Andrew Alper plans to sell up to 10,000 Lazard shares under Rule 144.

Expected impact

Potential slight dip in LAZ price, likely limited to a few cents.

Evidence & confidence

The sale size is modest relative to Lazard's market cap, and the shares were acquired as compensation, so impact is expected to be minimal.

Market effects

Little effect on the broader financial advisory sector.

No notable regional impact.

Limited to investors tracking Lazard.

Counterpoint

The sale could be interpreted as a lack of confidence, prompting a short‑term sell‑off.

Key entities

  • Lazard Ltd.

    Global financial advisory and asset management firm.

  • Andrew Alper

    Former board member of Lazard.

Related articles

$LAZMedAI 8/10

Lazard Stock Plunges 14% in 6 Months: Buy the Dip or Cut Your Losses?

Lazard Inc. (LAZ) stock has fallen 14.1% in six months, underperforming peers like Virtu Financial (VIRT) and Jefferies Financial (JEF). Weak earnings, high costs, and macroeconomic uncertainty weigh on its outlook. Analysts revised 2026 earnings down 10.6%, though 2027 estimates show an 83.6% increase. The company's valuation is high, with a P/B ratio of 5.3X. Management targets long-term growth but near-term challenges persist.

$LAZMed

How Lazard’s (LAZ) Swiss Investment Banking Hire Will Impact DACH Advisory Ambitions

Lazard (LAZ) appointed Dr. Marco Superina as head of investment banking for Switzerland, focusing on M&A and capital solutions. The hire aims to strengthen Lazard's presence in the DACH region and engage with Swiss corporate and financial communities. Lazard projects $4.6 billion revenue and $573.6 million earnings by 2029, requiring 12.6% yearly revenue growth. The company recently increased its share repurchase authorization by $200 million, despite softer Q2 2026 earnings. Analysts have mixed

$LAZMed

Lazard, Inc. Q2 2026: Revenue $807.7M, EPS $0.03— 10-Q Summary

Lazard, Inc. (LAZ) reported Q2 2026 revenue of $807.7M, up 1% year over year, but profitability fell. Net income attributable to Lazard was $4.8M versus $55.3M a year earlier, and diluted EPS was $0.03 versus $0.52. Adjusted net revenue rose modestly as Asset Management gains offset weaker Financial Advisory fees. Lazard agreed to acquire Campbell Lutyens, with potential earnouts totaling about $660M+, expected to close in 2H 2026.

$LAZMed

Lazard Poaches From Goldman, AllianceBernstein for Asset Manager

Lazard Asset Management hired Chris Hogbin’s team, adding TP Enders from Goldman Sachs as head of product and Christopher Bricker from AllianceBernstein to lead corporate development. The moves follow Lazard reporting record client assets and $7.4 billion of first-half inflows, despite a $1.4 billion May withdrawal that cut Lazard shares about 13% on disclosure. Lazard oversees $285 billion.